Videa Caries Assist

K213795

VideaHealth, Inc · cleared 2022-04-21 · product code MYN · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.7)
The subject device is a software-only device.
AlgorithmSupervised Deep Learning
source quote (p.6)
Supervised Deep Learning
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Standalone

n=1,034 images · 10 site(s)

endpoints: Overall average Alternative Free-response Receiver Operating Characteristic Figure of Merit (AFROC FOM); average image-based Sensitivity; average image-based PPV; average lesion-based Sensitivity; average lesion-based PPV

Reader study (MRMC)

n=226 images · 10 site(s)

endpoints: determine whether the diagnostic accuracy of readers aided by VCA is superior to reader accuracy when unaided by VCA, as determined by the AFROC Figure of Merit (AFROC FOM)

Reported performance (4 observations)

sensitivity70.8CI (68.0, 73.7)
source quote (p.7)
Overall average Se - image-based (%) 70.8 (68.0, 73.7)
aurocas written: “auc0.74CI (0.721, 0.760)
source quote (p.7)
Overall average FOM 0.740 (0.721, 0.760)
ppvas written: “Overall average PPV - image-based (%)59.5CI (56.5, 62.5)
source quote (p.7)
Overall average PPV - image-based (%) 59.5 (56.5, 62.5)
ppvas written: “Overall average PPV (%) - lesion-based (pooled)64.9CI (62.3, 67.6)
source quote (p.7)
Overall average PPV (%) - lesion-based (pooled) 64.9 (62.3, 67.6)

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
-100%
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K213795